Mareike Lohse

Mareike Lohse

Auto-generated profile, based on publicly available information

Mareike Lohse

Department of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
RAReza Asadollahi
Reza Asadollahi
AAAisha Ahmad
Aisha Ahmad
PBParanchai Boonsawat
Paranchai Boonsawat
JHJasmine Shahanoor Hinzen
Jasmine Shahanoor Hinzen
MLMareike Lohse
Mareike Lohse
NLNoa Lipstein
Noa Lipstein
The UNC13A gene encodes a presynaptic protein that is crucial for setting the strength and dynamics of information transfer between neurons. Here we describe a neurodevelopmental syndrome caused by germline coding or splice-site variants in UNC13A . The syndrome presents with variable degrees of developmental delay and intellectual disability, seizures of different types, tremor and dyskinetic movements and, in some cases, death in early childhood. Using assays with expression of UNC13A variants in mouse hippocampal neurons and in Caenorhabditis elegans , we identify three mechanisms of pathogenicity, including reduction in synaptic strength caused by reduced UNC13A protein expression, increased neurotransmission caused by UNC13A gain-of-function and impaired regulation of neurotransmission by second messenger signalling. Based on a strong genotype–phenotype-functional correlation, we classify three UNC13A syndrome subtypes (types A–C). We conclude that the precise regulation of neurotransmitter release by UNC13A is critical for human nervous system function.

13 February 2026 in Science Advances
Verified
Journal Article
Open access
MRMrinalini Ranjan
Mrinalini Ranjan
KLKun-Han Lin
Kun-Han Lin
BMBrian D. Mueller
Brian D. Mueller
SWSonja M. Wojcik
Sonja M. Wojcik
MLMareike Lohse
Mareike Lohse
HTHolger Taschenberger
Holger Taschenberger
Synaptic strength and plasticity are fine-tuned by neuromodulation and use-dependent second-messenger signaling. Presynaptic diacylglycerol (DAG), Ca 2+ , and Ca 2+ -calmodulin signaling converge on the essential synaptic vesicle (SV) priming protein Munc13-1 via its regulatory C 1 , C 2 B, and CaM-binding domains. Using brainstem-specific heterozygous mice expressing a DAG-binding-deficient Munc13-1 variant (Munc13-1 H567K ), we compared synaptic transmission in situ at glutamatergic calyx of Held synapses carrying either a single Munc13-1 H567K or a single Munc13-1 wt allele. Munc13-1 H567K/− synapses show enhanced initial strength but impaired steady-state release and slower recovery from depression. These deficits result from an increased initial abundance of fully primed SVs and a loss of activity-dependent acceleration of SV priming. Posttetanic potentiation (PTP) is strongly reduced in Munc13-1 H567K/− synapses and either increased or attenuated by C 2 B mutations that enhance or weaken Ca 2+ -phospholipid binding. Our data identify Munc13-1 as a target of presynaptic TrkB–phospholipase C–γ signaling and demonstrate that C 1 and C 2 B domain-dependent regulation of Munc13-1 determines synaptic strength and shapes short-term plasticity and PTP.